Loading stock data…
Lumexa Imaging Holdings, Inc. (LMRI)
$11.48-0.62 (-5.12%)
Market ClosedLast close Jun 29
Lumexa Imaging Holdings, Inc.
Historical Price
Price (Candle)
Synthesizing Whystock Narrative...
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Total Revenue | $252.54M↓ | $267.73M | — | $245.00M↓ | $248.03M |
| Gross Profit | $34.78M↓ | $42.12M | — | $36.60M↑ | $21.57M |
| Operating Income | $4.53M↑ | -$7.47M | — | $10.06M↑ | -$8.40M |
| Net Income | $1.72M↑ | -$28.69M | — | -$7.69M↑ | -$25.06M |
Peer Comparison
JNJUNHPFE
Fundamentals
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomog...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$746.55M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-9.96%
Volume
Today's trading volume
802,708
Recent News
Wall Street Analysts Believe Lumexa (LMRI) Could Rally 73.25%: Here's is How to Trade
The consensus price target hints at a 73.3% upside potential for Lumexa (LMRI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Breakeven Is Near for Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI)
With the business potentially at an important milestone, we thought we'd take a closer look at Lumexa Imaging Holdings...
Lumexa Imaging (LMRI) Q4 2025 Earnings Transcript
The fourth quarter of 2025 marked a strong close to an important year for Lumexa Imaging, and we delivered steady and consistent growth in revenue and EBITDA that exceeds our preliminary earnings announcement. Adjusted EBITDA of $63.8 million represented an 18.6% increase over Q4 of last year and delivered a 23.8% adjusted EBITDA margin. 2025 was a year marked by several meaningful achievements for Lumexa Imaging.
Lumexa (LMRI) Q1 2026 Earnings Transcript
In Q1, we delivered several meaningful achievements to kick off a year at executing on our strategic priorities, which include driving strong same centric growth, an expanding mix of advanced modalities, targeting a record number of de novo openings, ensuring the successful ramp of newly opened centers, accelerating high impact strategic service lines, and expanding our geographic footprint. Specifically, we drove strong same center growth and strategic service lines are expanding among a healthy mix of advanced modalities. In Q1, advanced modalities grew 7% year over year with pet growing at 23.1% year over year and MRI growing at 8.2% year over year.
Lumexa Imaging Holdings Inc (LMRI) Q1 2026 Earnings Call Highlights: Revenue Growth and ...
Discover how Lumexa Imaging Holdings Inc (LMRI) navigated revenue growth, strategic expansions, and operational challenges in Q1 2026.